By Rachel Graf ( September 28, 2017, 5:31 PM EDT) -- Valeant Pharmaceuticals International Inc. misrepresented to investors that its growth was driven by acquisitions rather than by deceptive sales practices, ultimately causing shares to plunge more than 90 percent, shareholders claimed Wednesday in New Jersey federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.